When did Medtronic report Q1 2026 earnings?

Medtronic (MDT) reported Q1 2026 earnings on August 19, 2025 before market open.

What were Medtronic's Q1 2026 revenue and EPS?

Medtronic reported revenue of $8.6B and diluted EPS of $1.26 for Q1 2026.

Did Medtronic beat estimates in Q1 2026?

Revenue beat the consensus estimate of $8.4B by $199.4M. EPS beat the consensus estimate of $1.23 by $0.03.

How did Medtronic's Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 8.4% from $7.9B a year earlier and diluted EPS grew 2.4% from $1.23.

Where can I find Medtronic's Q1 2026 SEC filings?

You can read the 10-Q periodic report (0001613103-25-000161) directly on SEC EDGAR. The filing index links above go to sec.gov.

Medtronic MDT Q1 2026 earnings

Reported August 19, 2025 · Before market open

Revenue$8.6BBeat by $199.4M Diluted EPS$1.26Beat by $0.03

Revenue estimate$8.4B

EPS estimate$1.23

Next report

Aug 18, 2026 (in 2 months)

Revenue estimate$9.6B

EPS estimate$1.39

Financials

Q1 2026

Income statement

See full

Revenue$8.6B+8.4%

Gross profit$5.6B+8.2%

Operating income$1.4B+13.1%

Net income$1.0B-0.2%

EPS (diluted)$0.81+1.3%

Balance sheet

See full

Cash & equivalents$1.3B-2.9%

Total debt$28.7B+2.7%

Total equity$47.9B-0.1%

Total assets$91.0B+1.4%

Cash flow

See full

Operating cash flow$1.1B+10.3%

CapEx$504.0M-3.1%

Free cash flow$584.0M+25.3%

Valuation & ratios

Valuation

as of 07/25/25

See full

Market cap$115.62B+8.9%

Enterprise value$143.01B+7.7%

P/E24.8×-2.2×

P/S3.4×+0.1×

Profitability

See full

Gross margin65.3%+0.1pp

Operating margin17.9%+2.1pp

Net margin13.6%+1.6pp

FCF margin15.5%-0.3pp

Returns & leverage

See full

Return on equity9.7%+1.8pp

Debt / equity0.6×0.0×

Current ratio2×-0.1×

Segments

By segment

See full

Cardiovascular$3.3B+9.2%

Neuroscience$2.4B+4.3%

Medical Surgical$2.1B+4.4%

Diabetes$721.0M+11.4%

Other operating segment$33.0M-13.2%

Versus estimates

Revenue

Q4 2026$9.8BBeat by $192.1M Q3 2026$9.0BBeat by $106.1M Q2 2026$9.0BBeat by $94.0M

Q1 2026$8.6BBeat by $199.4M

Q4 2025$8.9BBeat by $108.4M Q3 2025$8.3BMiss by $35.4M

Diluted EPS

Q4 2026$0.96Miss by $0.58 Q3 2026$1.36Beat by $0.02 Q2 2026$1.36Beat by $0.05

Q1 2026$1.26Beat by $0.03

Q4 2025$1.62Beat by $0.04 Q3 2025$1.39Beat by $0.03

Ask the moment Medtronic reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Medtronic report Q1 2026 earnings?: Medtronic (MDT) reported Q1 2026 earnings on August 19, 2025 before market open.
What were Medtronic's Q1 2026 revenue and EPS?: Medtronic reported revenue of $8.6B and diluted EPS of $1.26 for Q1 2026.
Did Medtronic beat estimates in Q1 2026?: Revenue beat the consensus estimate of $8.4B by $199.4M. EPS beat the consensus estimate of $1.23 by $0.03.
How did Medtronic's Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 8.4% from $7.9B a year earlier and diluted EPS grew 2.4% from $1.23.
Where can I find Medtronic's Q1 2026 SEC filings?: You can read the 10-Q periodic report (0001613103-25-000161) directly on SEC EDGAR. The filing index links above go to sec.gov.